Clinical Outcomes of Everolimus Rechallenge in Patients with Pancreatic Neuroendocrine Neoplasms with No Other Treatment Options

Clinical Outcomes of Everolimus Rechallenge in Patients with Pancreatic Neuroendocrine Neoplasms with No Other Treatment Options

Background: The clinical outcomes of everolimus rechallenge in patients with pancreatic neuroendocrine neoplasms (PNENs) are unknown. This study aimed to investigate the treatment outcomes and safety of everolimus rechallenge treatment with PNENs. Methods: Clinical data of everolimus-treated patient...

Full description

Bibliographic Details
Main Authors: Yusuke Kurita, Noritoshi Kobayashi, Kazuo Hara, Nobumasa Mizuno, Takamichi Kuwahara, Nozomi Okuno, Shin Haba, Motohiko Tokuhisa, Sho Hasegawa, Kensuke Kubota, Atsushi Nakajima, Yasushi Ichikawa
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
pancreas
neuroendocrine neoplasms
everolimus
Online Access:https://www.mdpi.com/2072-6694/14/22/5669

Internet

https://www.mdpi.com/2072-6694/14/22/5669

Similar Items